Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirocco: AZD3480 in Alzheimer's Disease
NCT00501111Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of ispronicline in Alzheimer's disease (AD), sponsored by AstraZeneca. Started Jul 2007; status: completed.
02
Drugs
ispronicline
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00501111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501111.